Veysel Özgür Barış

7PUBLICATIONS
84CO-AUTHORS
Concurrency theoryCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Macromolecular and materials chemistry not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 17, 2026
Diagnostic Adequacy of Pre-TAVI CTA Compared With ICA and Its Prognostic Association With Coronary Artery Disease.

|Jan 28, 2025
Incidence and Predictors of Clinical Outcomes in Real-Life Patients With Atrial Fibrillation Treated With Oral Factor Xa Inhibitors: The Follow-Up Results of the ANATOLIA-AF Study.

Umut Kocabaş, Isil Ergin, Sadi Can Sönmez

|Nov 28, 2024
Fixed-Dose Antiplatelet Dual Combination in Patients with Coronary Artery Disease in Turkish Population: DAPT-TR.

Ahmet Öz, Kenan Toprak, Ertan Aydin

|Nov 02, 2023
Empagliflozin attenuates doxorubicin-induced cardiotoxicity.

Veysel Özgür Barış, Adnan Berk Dinçsoy, Esra Gedikli

|Jun 05, 2021
Empagliflozin Significantly Prevents the Doxorubicin-induced Acute Cardiotoxicity via Non-antioxidant Pathways.

Veysel Özgür Barış, Adnan Berk Dinçsoy, Esra Gedikli

|Apr 16, 2020
Caseous calcification of the mitral annulus; scary image during robotic surgery.

Serkan Asil, Ender Murat, Veysel Özgür Barış

Pageof 2

Frequent Collaborators

2 joint publications

Serkan Asil

2 joint publications

Selda Murat

2 joint publications

Mustafa Doğduş

2 joint publications

Aslan Erdoğan